GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > cmed worth 43$ CASH and trading at 31.xx

<< Previous

Bullboard Posts

Next >>

Comment by Thryfteon Feb 06, 2018 3:10pm

119 Views

Post# 27513254

RE:cmed worth 43$ CASH and trading at 31.xx

Yes, it means it's extremely undervalued. I got a bunch at $39 just because of the conversion rate, got a few more at $26.80 because there's never been a more obvious buy. Getting this for under $40 seems a hit of a no-brainer to me, it's one of those things that seems too good to be true. Hopefully nothing happens to mess everything up! Just gotta hold on for a month and you get free money... in theory.

Dontbesogreedy wrote: the deal now have a 100% cash option (up to 140 millions) meaning that if 100% of cmed choose this cash option (very unlikely) a minimum of 13.3% of your shares could be worth 43$ cash and the rest would be worth 3.4 ACB shares (at the time of typing this 3.4 ACB is worth about 34$)

Does this make cmed WAY undervalued?

Pursuant to the terms of the Notice of Variation, Aurora has increased the consideration offered per CanniMed Share, at the election of each CanniMed shareholder, to: (a) 3.40 common shares ("Aurora Shares") of Aurora (the "Share Alternative"); (b) $43.00 in cash (subject to proration); (the "Cash Alternative"); or (c) any combination thereof (subject to proration of the cash portion), (the "Share and Cash Alternative").